検索結果 - John M McLaughlin
-
1
A Letter to the Editor Regarding ‘Comparative Effectiveness of mRNA-1273 and BNT162b2 COVID-19 Vaccines Among Older Adults: Systematic Literature Review and Meta-analysis Using the... 著者: Hannah R. Volkman, Jennifer L. Nguyen, Luis Jodar, John M. McLaughlin
出版年 Infectious Diseases and Therapy (2024-08-01)全文の入手
論文 -
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
Pneumococcal conjugate vaccine use for the prevention of pneumococcal disease in adults <50 years of age 著者: Raul E. Isturiz, Cassandra Hall-Murray, John M. McLaughlin, Vincenza Snow, Beate Schmoele-Thoma, Chris Webber, Allison Thompson, Daniel A Scott
出版年 Expert Review of Vaccines (2018-01-01)全文の入手
論文 -
12
-
13
Pandemic-related declines in hospitalization for non-COVID-19-related illness in the United States from January through July 2020. 著者: Jennifer L Nguyen, Michael Benigno, Deepa Malhotra, Farid Khan, Frederick J Angulo, Jennifer Hammond, David L Swerdlow, Maya Reimbaeva, Birol Emir, John M McLaughlin
出版年 PLoS ONE (2022-01-01)全文の入手
論文 -
14
Estimated global public health and economic impact of COVID-19 vaccines in the pre-omicron era using real-world empirical data 著者: Jingyan Yang, Shailja Vaghela, Benjamin Yarnoff, Solene De Boisvilliers, Manuela Di Fusco, Timothy Lee Wiemken, Moe H. Kyaw, John M. McLaughlin, Jennifer L. Nguyen
出版年 Expert Review of Vaccines (2023-12-01)全文の入手
論文 -
15
Factors affecting the impact of COVID-19 vaccination on post COVID-19 conditions among adults: A systematic literature review 著者: Abby E. Rudolph, Nadine Al Akoury, Natalija Bogdanenko, Kristen Markus, Isabelle Whittle, Olivia Wright, Hammam Haridy, Julia R. Spinardi, John M. McLaughlin, Moe H. Kyaw
出版年 Human Vaccines & Immunotherapeutics (2025-12-01)全文の入手
論文 -
16
Perceived Risk for Severe COVID-19 and Oral Antiviral Use Among Antiviral-Eligible US Adults 著者: Kate Penrose, Avantika Srivastava, Yanhan Shen, McKaylee M. Robertson, Sarah G. Kulkarni, Kristen E. Allen, Thomas M. Porter, Laura Puzniak, John M. McLaughlin, Denis Nash
出版年 Infectious Diseases and Therapy (2024-06-01)全文の入手
論文 -
17
Nirmatrelvir/Ritonavir Utilization for the Treatment of Non-hospitalized Adults with COVID-19 in the National Veterans Affairs (VA) Healthcare System 著者: Haley J. Appaneal, Kerry L. LaPlante, Vrishali V. Lopes, Catherine Martin, Laura Puzniak, Timothy L. Wiemken, Evan J. Zasowski, John M. McLaughlin, Aisling R. Caffrey
出版年 Infectious Diseases and Therapy (2024-01-01)全文の入手
論文 -
18
Association between nirmatrelvir/ritonavir treatment and antibiotic prescribing in the outpatient setting among patients with COVID-19 著者: Aisling R. Caffrey, Haley J. Appaneal, Vrishali V. Lopes, Thomas Lavoie, Laura Puzniak, Evan J. Zasowski, Luis Jodar, Iqra Arham, Kerry L. LaPlante, John M. McLaughlin
出版年 Microbiology Spectrum (2025-04-01)全文の入手
論文 -
19
Predictors of nirmatrelvir–ritonavir receipt among COVID-19 patients in a large US health system 著者: Deborah E. Malden, John M. McLaughlin, Vennis Hong, Joseph Lewnard, Bradley K. Ackerson, Laura Puzniak, Jeniffer S. Kim, Harpreet Takhar, Timothy B. Frankland, Jeff M. Slezak, Sara Y. Tartof
出版年 Scientific Reports (2024-03-01)全文の入手
論文 -
20
COVID-19 Vaccine Effectiveness: A Review of the First 6 Months of COVID-19 Vaccine Availability (1 January–30 June 2021) 著者: Sarah M. Hatcher, Stacy M. Endres-Dighe, Frederick J. Angulo, Amit Srivastava, Jennifer L. Nguyen, Farid Khan, Catherine Martin, David L. Swerdlow, John M. McLaughlin, Nneka Ubaka-Blackmore, Linda Morris Brown
出版年 Vaccines (2022-03-01)全文の入手
論文